Élise Verron

2.3k total citations · 1 hit paper
40 papers, 1.8k citations indexed

About

Élise Verron is a scholar working on Biomedical Engineering, Oncology and Surgery. According to data from OpenAlex, Élise Verron has authored 40 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Biomedical Engineering, 11 papers in Oncology and 9 papers in Surgery. Recurrent topics in Élise Verron's work include Bone Tissue Engineering Materials (18 papers), Bone health and treatments (11 papers) and Dental Implant Techniques and Outcomes (8 papers). Élise Verron is often cited by papers focused on Bone Tissue Engineering Materials (18 papers), Bone health and treatments (11 papers) and Dental Implant Techniques and Outcomes (8 papers). Élise Verron collaborates with scholars based in France, Australia and United Arab Emirates. Élise Verron's co-authors include Jean‐Michel Bouler, Paul Pilet, Jean‐Claude Scimeca, Jérôme Guicheux, O. Gauthier, Bruno Bujoli, I. Khaϊroun, Ramin Rohanizadeh, Pascal Janvier and Zahi Badran and has published in prestigious journals such as Biomaterials, Chemistry of Materials and Advanced Drug Delivery Reviews.

In The Last Decade

Élise Verron

39 papers receiving 1.7k citations

Hit Papers

Biphasic calcium phosphate ceramics for bone reconstructi... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Élise Verron France 25 1.1k 402 356 299 297 40 1.8k
Yoshitomo Honda Japan 27 1.5k 1.3× 487 1.2× 586 1.6× 550 1.8× 446 1.5× 106 2.3k
Olivier Gauthier France 27 1.2k 1.0× 658 1.6× 503 1.4× 171 0.6× 326 1.1× 77 2.0k
Chih‐Kuang Wang Taiwan 28 978 0.9× 424 1.1× 152 0.4× 498 1.7× 654 2.2× 66 2.3k
Yuanjin Xu China 21 1.1k 1.0× 393 1.0× 231 0.6× 617 2.1× 368 1.2× 40 2.1k
Takahisa Anada Japan 33 2.2k 1.9× 616 1.5× 656 1.8× 759 2.5× 647 2.2× 138 3.2k
Michela Bosetti Italy 24 1.2k 1.0× 638 1.6× 368 1.0× 288 1.0× 345 1.2× 76 2.2k
Zufu Lu Australia 30 1.6k 1.4× 718 1.8× 394 1.1× 486 1.6× 650 2.2× 73 2.7k
Damien Le Nihouannen France 18 1.2k 1.1× 372 0.9× 320 0.9× 172 0.6× 492 1.7× 26 1.6k
Sandra Sánchez‐Salcedo Spain 32 1.8k 1.6× 466 1.2× 533 1.5× 185 0.6× 566 1.9× 61 2.3k
Barbara Palazzo Italy 23 1.0k 0.9× 207 0.5× 239 0.7× 96 0.3× 640 2.2× 44 1.7k

Countries citing papers authored by Élise Verron

Since Specialization
Citations

This map shows the geographic impact of Élise Verron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Élise Verron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Élise Verron more than expected).

Fields of papers citing papers by Élise Verron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Élise Verron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Élise Verron. The network helps show where Élise Verron may publish in the future.

Co-authorship network of co-authors of Élise Verron

This figure shows the co-authorship network connecting the top 25 collaborators of Élise Verron. A scholar is included among the top collaborators of Élise Verron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Élise Verron. Élise Verron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chopra, Divya, et al.. (2025). Micro, nano and gallium: Bioactive and bactericidal gallium-eluting nano-engineered zirconia implants. Chemical Engineering Journal. 523. 168628–168628. 1 indexed citations
2.
Elmoselhi, Adel B., et al.. (2025). Immune and inflammatory responses in microgravity: implications and therapeutic approaches. Drug Discovery Today. 30(11). 104503–104503.
3.
Guo, Tianqi, Jean‐Claude Scimeca, Sašo Ivanovski, Élise Verron, & Karan Gulati. (2023). Enhanced Corrosion Resistance and Local Therapy from Nano-Engineered Titanium Dental Implants. Pharmaceutics. 15(2). 315–315. 21 indexed citations
4.
Gulati, Karan, et al.. (2023). Fit and forget: The future of dental implant therapy via nanotechnology. Advanced Drug Delivery Reviews. 199. 114900–114900. 52 indexed citations
5.
Badran, Zahi, et al.. (2023). Antibacterial nanophotosensitizers in photodynamic therapy: An update. Drug Discovery Today. 28(4). 103493–103493. 45 indexed citations
6.
Gulati, Karan, Jean‐Claude Scimeca, Sašo Ivanovski, & Élise Verron. (2021). Double-edged sword: Therapeutic efficacy versus toxicity evaluations of doped titanium implants. Drug Discovery Today. 26(11). 2734–2742. 36 indexed citations
7.
Bouler, Jean‐Michel, Paul Pilet, O. Gauthier, & Élise Verron. (2017). Biphasic calcium phosphate ceramics for bone reconstruction: A review of biological response. Acta Biomaterialia. 53. 1–12. 364 indexed citations breakdown →
8.
Schmid‐Antomarchi, Heidy, Annie Schmid‐Alliana, Florian Boukhechba, et al.. (2016). Gallium, a promising candidate to disrupt the vicious cycle driving osteolytic metastases. Biochemical Pharmacology. 116. 11–21. 19 indexed citations
9.
Verron, Élise, et al.. (2016). Molecular Mechanisms of Anti-metastatic Activity of Curcumin. Anticancer Research. 36(11). 5639–5648. 70 indexed citations
10.
Fayon, Franck, Florian Boukhechba, Élise Verron, et al.. (2015). Design and properties of novel gallium-doped injectable apatitic cements. Acta Biomaterialia. 24. 322–332. 43 indexed citations
11.
Verron, Élise, Julie Lesoeur, Verena Schnitzler, et al.. (2014). Vertebroplasty using bisphosphonate-loaded calcium phosphate cement in a standardized vertebral body bone defect in an osteoporotic sheep model. Acta Biomaterialia. 10(11). 4887–4895. 43 indexed citations
12.
Verron, Élise, et al.. (2014). Therapeutic strategies for treating osteolytic bone metastases. Drug Discovery Today. 19(9). 1419–1426. 44 indexed citations
13.
Verron, Élise & Jean‐Michel Bouler. (2013). Is bisphosphonate therapy compromised by the emergence of adverse bone disorders?. Drug Discovery Today. 19(3). 312–319. 36 indexed citations
14.
Verron, Élise, Jean‐Michel Bouler, & Jean‐Claude Scimeca. (2012). Gallium as a potential candidate for treatment of osteoporosis. Drug Discovery Today. 17(19-20). 1127–1132. 45 indexed citations
15.
Verron, Élise, Agnès Loubat, Georges F. Carle, et al.. (2011). Molecular effects of gallium on osteoclastic differentiation of mouse and human monocytes. Biochemical Pharmacology. 83(5). 671–679. 41 indexed citations
16.
Badran, Zahi, Paul Pilet, Élise Verron, et al.. (2011). Assay of in vitro osteoclast activity on dentine, and synthetic calcium phosphate bone substitutes. Journal of Materials Science Materials in Medicine. 23(3). 797–803. 10 indexed citations
17.
Verron, Élise, Olivier Gauthier, Pascal Janvier, et al.. (2010). In vivo bone augmentation in an osteoporotic environment using bisphosphonate-loaded calcium deficient apatite. Biomaterials. 31(30). 7776–7784. 78 indexed citations
18.
Verron, Élise, et al.. (2010). Analgesic properties of calcium phosphate apatite loaded with bupivacaine on postoperative pain. Journal of Biomedical Materials Research Part B Applied Biomaterials. 94B(1). 89–96. 15 indexed citations
19.
Verron, Élise, I. Khaϊroun, Jérôme Guicheux, & Jean‐Michel Bouler. (2010). Calcium phosphate biomaterials as bone drug delivery systems: a review. Drug Discovery Today. 15(13-14). 547–552. 163 indexed citations
20.
Carbonnelle, Delphine, Alexandra Dassonville‐Klimpt, Élise Verron, et al.. (2007). Synthetic N-pyridinyl(methyl)-indol-3-ylpropanamides as new potential immunosuppressive agents. European Journal of Medicinal Chemistry. 42(5). 686–693. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026